Protect Pharmaceutical Corporation
PRTT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $132 | $136 | $82 | $79 |
| % Growth | -2.9% | 66.5% | 3.8% | – |
| Cost of Goods Sold | $60 | $63 | $40 | $34 |
| Gross Profit | $73 | $73 | $42 | $44 |
| % Margin | 54.9% | 53.8% | 50.8% | 56.3% |
| R&D Expenses | $3 | $5 | $2 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12 | $21 | $15 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $15 | $26 | $16 | $16 |
| Operating Income | $58 | $48 | $25 | $28 |
| % Margin | 43.6% | 34.9% | 30.9% | 35.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $58 | $48 | $25 | $28 |
| Tax Expense | $1 | $2 | $3 | $8 |
| Net Income | $56 | $46 | $22 | $20 |
| % Margin | 42.6% | 33.7% | 27.4% | 25.6% |
| EPS | 0.98 | 0.8 | 0.43 | 0.36 |
| % Growth | 22.5% | 86% | 19.4% | – |
| EPS Diluted | 0.98 | 0.8 | 0.43 | 0.36 |
| Weighted Avg Shares Out | 57 | 57 | 53 | 56 |
| Weighted Avg Shares Out Dil | 57 | 57 | 53 | 56 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $58 | $48 | $25 | $28 |
| % Margin | 43.6% | 35% | 31.2% | 35.7% |